B2B App Monetisation and Distribution in 2026: What's Actually Changed (And What Shouldn't)

Most indie SaaS developers build in private and then panic once they go public.

The product works. Users like it. There might even be a handful of paying customers who found it through a ProductHunt launch or a Reddit thread. But the question of how to actually grow, how to get the software in front of the right people, reliably, at scale, tends to arrive late and hit hard.

Distribution is the part of the SaaS playbook that nobody teaches properly. And in 2026, with more software being built than at any point in history, getting it wrong is more expensive than ever.

Here's what the landscape actually looks like right now.

The monetisation shift you need to understand

The B2B SaaS pricing conversation has moved on significantly in the last two years. The general trend is moving away from charging for access to software, ie seats, and toward charging for the work delivered: usage, outcomes, and results.

61% of SaaS companies now use hybrid pricing models, a base subscription combined with usage-based charges tied to consumption, (Source: Metronome / OpenView Partners, 2025). Pure per-seat pricing now accounts for only 15% of the SaaS market, down from 21% twelve months ago (Source: Colorlib SaaS Statistics 2026).

For large, well-funded SaaS companies, this transition makes sense. They have the infrastructure to meter usage, the customer success teams to manage outcome-based contracts, and the data to price with confidence.

For indie developers and small teams building niche vertical tools? It's mostly noise. Here's why.

The businesses that allied health and field service tools are built for, a physiotherapy practice with four clinicians, a field service company with twelve engineers, are not evaluating hybrid pricing tiers or outcome-based contracts. They want to know what it costs per month, whether it does what they need, and whether someone will answer the phone if it breaks.

Simple, honest, flat pricing is still the right model for niche SME software. Not because the market hasn't evolved, but because your customers’ needs haven’t changed. They want software that solves a specific problem without making them feel like they need a procurement team to understand the invoice.

Vertical SaaS specialists are outperforming horizontal platforms, with industry-specific SaaS growing at 18–32% annually, compared to 12–15% for horizontal tools (Source: SaaStr, cited in Modall SaaS Trends 2026). The market is rewarding exactly the kind of focused, specific tools that indie developers are best positioned to build. The monetisation complexity being adopted at the top end of the market is not a template to follow, it's a distraction.

Distribution models: what they are and what they actually cost you

There are broadly four ways to get niche B2B software to market. Each has real tradeoffs that rarely get discussed.

Direct sales. You find the customers, close them, onboard them, support them. You keep all the revenue. You also spend the majority of your time on sales and support rather than product. For a developer who built a tool because they're good at solving problems, not selling solutions, this model is slow, expensive, and deeply uncomfortable. It works eventually, but "eventually" is a long time when you're funding it yourself.

App marketplaces. The appeal is obvious, someone else has the audience, you just list your product. The reality is more complicated. General marketplaces like the Salesforce AppExchange or HubSpot Marketplace work well if your tool integrates tightly with a dominant platform your buyers already use. For standalone niche tools targeting a specific profession rather than a specific tech stack, the fit is often poor. You're a physio scheduling tool in a marketplace full of CRM extensions. The audience isn't there.

Rev-share partnerships. You find a partner with distribution, a trade association, an accounting firm, a healthcare technology provider, and split revenue in exchange for access to their audience. When it works, it's extremely effective. The partner has trust, relationships, and reach that would take years to build independently. The challenge is finding and closing those partnerships in the first place, negotiating commercial terms that work for both sides, and maintaining the relationship as your product evolves. It's not passive.

Reseller models. A third party acquires or licenses your software and takes on commercial ownership- sales, marketing, customer relationships. You receive a revenue share or ongoing royalty, and in some cases continue to handle product development and technical support. For developers who want to stay in the product and get out of the go-to-market, this is often the most practical path and the most underused.

The honest answer is that most niche SaaS tools need a combination: a reseller or distribution partner to handle the commercial layer, direct relationships with a core group of early customers who provide feedback and social proof, and eventually a marketplace presence once the product has enough traction to be discoverable.

Why allied health and FSM are distribution gaps, not distribution problems

There's an important distinction between a market that's hard to reach and a market that nobody has built the infrastructure to reach yet.

Allied health and field service management are the second kind.

The professionals in these markets- physiotherapists, chiropractors, gas engineers, electrical contractors are not hard to find. They have trade associations, professional bodies, sector-specific publications, CPD events, and active online communities. The audience is organised and reachable.

What's missing is a trusted intermediary who understands both the software and the sector. Someone who has done the compliance and evaluation work, who speaks the language of the clinician or the field engineer, and who can put a credible tool in front of the right person without it feeling like a cold pitch from a software company they've never heard of.

52.7% of purchased SaaS licences sit idle, costing organisations an average of $21 million annually, according to Zylo's 2025 SaaS Management Index. In sectors like allied health, where practices are small and time is genuinely scarce, that number is likely higher. The problem isn't willingness to pay for software, it's confidence that the software is worth paying for and will actually get used.

That's a distribution problem with a known solution: curation, trust, and a commercial layer that takes the evaluation burden off the buyer.

What this means if you're building niche vertical software

A few things worth sitting with:

Your pricing architecture matters more than your pricing level. Clear, honest, flat pricing signals that you built something to be used. Complexity signals that you built something to be sold.

Your distribution model is a product decision, not just a commercial one. Who sells your software, and how, shapes how it's perceived, supported, and retained. A reseller or distribution partner who doesn't understand your market will undermine the product regardless of how good it is.

The gap between product quality and market penetration is the real opportunity in niche vertical SaaS right now. Vertical SaaS is growing at 18–32% annually. The infrastructure to distribute it well, in most niches, is still being built.

If you've built something genuinely useful for an underserved market and you're trying to figure out the commercial layer- it’s a solvable problem. It just requires a different kind of partner than the ones most developers think to look for.

Myriad finds, evaluates, and distributes under-marketed SaaS for UK allied health and field service management (with more on the way soon). If you've built something that deserves a bigger stage get in touch below!